NYSE:CANO - Cano Health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $10.90
  • Forecasted Upside: 126.61 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$4.81
▲ +0.21 (4.57%)

This chart shows the closing price for CANO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cano Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CANO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CANO

Analyst Price Target is $10.90
▲ +126.61% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Cano Health in the last 3 months. The average price target is $10.90, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 126.61% upside from the last price of $4.81.

This chart shows the closing price for CANO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 8 investment analysts is to buy stock in Cano Health.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 1 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 1 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 1 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/24/2022Raymond JamesInitiated CoverageOutperform$8.00Low
6/15/2022Bank of AmericaDowngradeBuy ➝ Neutral$8.00 ➝ $6.00High
5/17/2022UBS GroupLower Price TargetNA$14.00High
5/10/2022Piper SandlerLower Price Target$5.00 ➝ $4.00Medium
5/10/2022CowenLower Price Target$13.00 ➝ $10.00High
5/10/2022CowenLower Price Target$13.00 ➝ $10.00High
5/10/2022CitigroupLower Price Target$10.00 ➝ $8.00High
5/3/2022Bank of AmericaInitiated CoverageBuy$8.00High
4/20/2022UBS GroupInitiated CoverageBuy$15.00High
4/6/2022Piper SandlerDowngradeNeutral ➝ Underweight$8.50 ➝ $5.00High
3/16/2022Credit Suisse GroupLower Price TargetOutperform$15.00 ➝ $13.00High
3/16/2022CitigroupLower Price Target$12.00 ➝ $10.00High
12/7/2021CowenLower Price TargetOutperform$18.00 ➝ $15.00Medium
11/10/2021Piper SandlerBoost Price TargetNeutral$11.00 ➝ $13.00High
10/20/2021Jefferies Financial GroupInitiated CoverageBuy$17.00High
10/19/2021Piper SandlerInitiated CoverageNeutralLow
10/1/2021Wolfe ResearchInitiated CoverageOutperform$19.00High
9/21/2021CitigroupInitiated CoverageBuy$20.00High
9/9/2021CowenInitiated CoverageOutperform$18.00High
8/2/2021Credit Suisse GroupInitiated CoverageOutperform$18.00High
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.18 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2021
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/6/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/5/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/7/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
4/6/2022
  • 3 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/6/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
6/5/2022
  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/5/2022

Current Sentiment

  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Cano Health logo
Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. As of December 31, 2021, it operated 130 owned medical centers and approximately 1000 affiliate providers serving approximately 227,005 members. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.
Read More

Today's Range

Now: $4.81
Low: $4.44
High: $4.92

50 Day Range

MA: $5.13
Low: $4.14
High: $6.03

52 Week Range

Now: $4.81
Low: $3.81
High: $15.58

Volume

3,154,591 shs

Average Volume

3,659,764 shs

Market Capitalization

$2.33 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24

Frequently Asked Questions

What sell-side analysts currently cover shares of Cano Health?

The following Wall Street analysts have issued stock ratings on Cano Health in the last year: Bank of America Co., Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, Jefferies Financial Group Inc., Piper Sandler, Raymond James, UBS Group AG, and Wolfe Research.
View the latest analyst ratings for CANO.

What is the current price target for Cano Health?

0 Wall Street analysts have set twelve-month price targets for Cano Health in the last year. Their average twelve-month price target is $10.90, suggesting a possible upside of 126.6%.
View the latest price targets for CANO.

What is the current consensus analyst rating for Cano Health?

Cano Health currently has 1 sell rating, 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CANO will outperform the market and that investors should add to their positions of Cano Health.
View the latest ratings for CANO.

How do I contact Cano Health's investor relations team?

Cano Health's physical mailing address is 1601 WASHINGTON AVENUE SUITE 800, MIAMI BEACH FL, 33139. The company's listed phone number is 855-226-6633 and its investor relations email address is [email protected] The official website for Cano Health is canohealth.com. Learn More about contacing Cano Health investor relations.